Mendus AB (publ) (STO:IMMU)
4.305
-0.345 (-7.42%)
Mar 2, 2026, 5:12 PM CET
Mendus AB Employees
Mendus AB had 20 employees as of December 31, 2025. The number of employees decreased by 8 or -28.57% compared to the previous year.
Employees
20
Change (1Y)
-8
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-5.66M SEK
Market Cap
264.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | -8 | -28.57% |
| Dec 31, 2024 | 28 | -2 | -6.67% |
| Dec 31, 2023 | 30 | -4 | -11.76% |
| Dec 31, 2022 | 34 | 4 | 13.33% |
| Dec 31, 2021 | 30 | 1 | 3.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sprint Bioscience AB | 29 |
| Bio-Works Technologies AB | 26 |
| Intervacc AB | 15 |
| Xintela AB | 13 |
| Corline Biomedical AB | 13 |
| AlzeCure Pharma AB | 11 |
| Ascelia Pharma AB | 11 |
| Isofol Medical AB | 6 |